Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial
Kosiborod, Mikhail
( ST LUKES HEALTH SYSTEM
, Kansas City
, Missouri
, United States
)
Author Disclosures:
Mikhail Kosiborod:DO have relevant financial relationships
;
Consultant:35Pharma, Imbria Pharmaceuticals:Active (exists now)
; Consultant:Esperion Therapeutics, Structure Therapeutics:Active (exists now)
; Consultant:Eli Lilly, scPharmaceuticals:Active (exists now)
; Consultant:Dexcom, Sanofi, Youngene Therapeutics:Active (exists now)
; Consultant:Cytokinetics, Regeneron:Active (exists now)
; Consultant:Boehringer Ingelheim:Active (exists now)
; Research Funding (PI or named investigator):Boehringer Ingelheim:Active (exists now)
; Consultant:Bayer, Pharmacosmos:Active (exists now)
; Other (please indicate in the box next to the company name):AstraZeneca, Vifor Pharma - data analytic center fees:Active (exists now)
; Consultant:AstraZeneca, Pfizer, Vifor Pharma:Active (exists now)
; Research Funding (PI or named investigator):AstraZeneca, Pfizer:Active (exists now)
; Consultant:Arrowhead Pharmaceuticals:Active (exists now)
; Consultant:Applied Therapeutics:Active (exists now)
; Consultant:Amgen, NovoNordisk:Active (exists now)
; Consultant:Alnylam, Merck (Diabetes and Cardiovascular):Active (exists now)